by Allison Sit Dermatology Advisor, Dermatology News, Healio, Medriva and Medscape all covered a Journal of Drugs in Dermatology study about the long-term safety and effectiveness of topical clascoterone for…
Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This altered adage rings true in the house of medicine, most notably at the crux…
by Allison Sit The Journal of Drugs in Dermatology made news in Healio recently with several articles including one about a combination therapy for non-melanoma skin cancer. The study, “Cryosurgery…
Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for you acne!) which unapologetically imparts a tremendous burden on society as a whole. But what if you could…
by Allison Sit Healio wrote about a recent Journal of Drugs in Dermatology study on telehealth usage from a physician’s perspective. The study, “Telemedicine Versus Teledermatology Usage and Perception Among…
by Allison Sit A Journal of Drugs in Dermatology study on the availability of oral minoxidil made news in several media outlets, including NBC News, HealthDay, Practical Dermatology and Dermatology…
By Allison Sit Physician organizations including the American Academy of Dermatology (AAD) are raising alarm about finalized cuts to the Medicare physician fee schedule for 2024. AAD President Terrence A….